Innovassynth Technologies (india) Ltd · BSE:INOVSYNTH
Innovassynth Technologies (india) — Q4 FY26 Earnings Presentation
15 slides from Innovassynth Technologies (india)'s earnings presentation, May 31, 2026
Slide 1: Cover letter to BSE: Investor Presentation
Date: May 31, 2026 To, Manager, Corporate Relationship Department, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400001 Scrip Code: 533315 Dear Sir/Madam, Sub: Investor Presentation With reference to the subject, please find enclosed the Investor Presentation for the quarter and year e
Slide 2: Investor Presentation Q4FY26
Investor Presentation Q4FY26 31-May-2026
Slide 3: Disclaimer
Disclaimer “This presentation has been prepared by Innovassynth Technologies India Limited (“Company”) (formerly known as Innovassynth Investments Limited). The presentation aims to cover key financial and business highlights. This presentation and some statements herein may be forward-looking state
Slide 4: Executive Summary and Financials
Executive Summary and Financials 3
Slide 5: Executive Summary: Performance Update and Outlook
Executive Summary Performance Update and Outlook • Performance during the previous quarter was impacted by temporary shipment delays arising from logistics disruptions due to the ongoing Middle East conflict, as well as a one-time inventory adjustment by a key customer • These factors were transitor
Slide 6: Executive Summary: Execution Highlight and Growth Drivers
Executive Summary Execution Highlight and Growth Drivers • Life sciences capacity expansion underway, expected to increase capacity by 2x aligned with CDMO demand growth • Successfully completed audits from two large CDMO customers with no major observations, reinforcing strong quality systems • Two
Slide 7: Strategic Growth & Business Development Highlights
Strategic Growth & Business Development Highlights Open Order Book Amount in INR Crores Life Sciences Specialty Chemicals CRDMO Grand Total INR ~126 INR ~22 INR ~28 INR ~176 Major orders from a USA- Strong portfolio product Confirmed requirements based companies, with strategy to capture shared by l
Slide 8: Profit and Loss Statement
Profit and Loss Statement Particulars Quarter Ended Year Ended Year Ended 31-Mar-2026 31-Dec-2025 31-Mar-2025 31-Mar-2026 31-Mar-2025 Revenue from operations 5083 2197 4841 10235 9831 Operating Expenses (4455) (2604) (3801) (12677) (7671) EBIDTA 628 (407) 1040 (2441) 2160 EBIDTA Margin (%) 12% -19%
Slide 9: Balance Sheet
Balance Sheet Particulars FY26 FY25 Particulars FY26 FY25 Assets Equity and Liabilities Non-Current Assets Equity Property, Plant and Equipment 12160 11880 Equity, Shared Capital 7545 2798 Right of use assets 786 933 Equity Share capital to be issues on account of merger 4746 Capital work-in-progres
Slide 10: Company Overview
Company Overview 9
Slide 11: Business Model
Business Model Innovassynth has 3 business units Contract Research Life Sciences & Nucleosides Specialty Chemicals Development and Manufacturing Exports Led Business : ~90% of revenue from global geographies with key focus on USA & EU Our Life Sciences & Specialty Chemicals segments focus on develop
Slide 12: Innovassynth – At a Glance
Innovassynth – At a Glance • Manufacturing plant in 60+ acres at Khopoli with 8 units • 60 fume hoods catering to custom • 10+ Line with total reaction Manufacturing development for FTE/FFS capacity of 250 KL+ R&D Facility Facility • Dedicated analytical lab • 50L to 10KL reactor sizes • Equipment o
Slide 13: Consistently Improving: Quality, Safety, Sustainability
Consistently Improving:Quality, Safety, Sustainability ISO 27001:2022, Ecovadis Gold Rating SBTi and ISO 14001:2015, for the second Responsible Care ISO 45001:2018, consecutive year initiated in 2026 ISO 9001:2015 Preparedness and Safety & Environmental Health & Continuous Training Infrastructure Mo
Slide 14: Capital Market Information
Capital Market Information 90000 BSE Sensex Vs Innovassynth (ITIL) Share Price 140 120 85000 100 80000 80 BSE 75000 60 ITIL 40 70000 20 65000 0 Apr-25 May-25 Jun-25 Jul-25 Aug-25 Sep-25 Oct-25 Nov-25 Dec-25 Jan-26 Feb-26 Mar-26 Shareholding Pattern (as on 31-Mar-26) DII and Mutual Price Data as on 3
Slide 15: Thank You
INN” VASSYNTH Thank You
Innovassynth Technologies (India) — Q4 FY26 Earnings Presentation on 6ix